Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study

Background: People with type 2 diabetes (T2D) are at an increased risk of severe hypoglycaemia when fasting. SOLIRAM is an international, prospective, observational study evaluating the safety and effectiveness of the fixed-ratio combination (FRC) of insulin glargine 100 U/mL and lixisenatide (iGlar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Mohamed, Sahay, Rakesh Kumar, Malek, Rachid, Shaltout, Inass, Djaballah, Khier, Demil, Nacima, Chao, Jason, Andersson, Helena M, Buyukbese, Mehmet Akif, Sifri, Saud Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090142/
http://dx.doi.org/10.1210/jendso/bvab048.681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090142/
http://dx.doi.org/10.1210/jendso/bvab048.681

Ejemplares similares